Clinical Trial Update: NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC [NA]

View source ↗

Summary

An ongoing trial is evaluating neoadjuvant chemoradiotherapy combined with sequential perioperative PD-1 inhibition for locally advanced esophageal squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: RenJi Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | NA | Status: ACTIVE_NOT_RECRUITING